程序性死亡因子1/程序性死亡因子1配体抑制剂治疗肾细胞癌有效性及安全性的Meta分析
张懂理, 沈冲, 张卫川, 陈海滨, 赵建军
Efficacy and Safety of Programmed Death-1/Programmed Death-1 Ligand Inhibitors in the Treatment of Renal Cell Cancer: a Meta-analysis
ZHANG Dongli, SHEN Chong, ZHANG Weichuan, CHEN Haibin, ZHAO Jianjun
中国全科医学
.
2023, (30): 3815
-3822
.
DOI: 10.12114/j.issn.1007-9572.2023.0180
